Table 2.
Characteristics of the study subjects with chronic thyroiditis (thyroiditis), Graves'disease (Graves') and controls‡
| Controls II | Thyroiditis | Graves' | P† | |
|---|---|---|---|---|
| n | 78 | 220 | 104 | |
| Gender (F/M) | 36/42 | 186/34* | 83/21* | 0·0001 |
| Age (years) | 55 ± 18 | 48 ± 15* | 44 ± 11* | 0·0001 |
| Body mass index (kg/m2) | 26·6 ± 5·1 | 25·6 ± 4·8 | 24·3 ± 4·4* | 0·02 |
| Echogenicity (units) | 0·43 ± 0·74 | 0·91 ± 0·86* | 1·29 ± 0·80* | 0·0001 |
| Thyroid volume (ml) | 19·3 ± 16·0 | 19·2 ± 18·3 | 28·7 ± 25·0* | 0·0001 |
| fT3 (ng/ml) | 3·70 ± 0·46 | 3·42 ± 1·2 | 4·34 ± 2·78* | 0·0001 |
| fT4 (nl/l) | 9·21 ± 1·73 | 9·92 ± 3·56 | 12·56 ± 6·86* | 0·01 |
| TSH (mUI/ml) | 1·34 ± 0·82 | 2·6 ± 7·2 | 1·00 ± 1·39* | 0·0001 |
‡
Data are mean ± s.d.;
†
by anova, Kruskall–Wallis or χ2 testing;
*
different from controls at the P < 0·05 level or less by Mann–Whitney or Bonferroni–Dunn test.